Endothelial progenitor cells: therapeutic perspective for ischemic stroke - PubMed (original) (raw)

Review

Endothelial progenitor cells: therapeutic perspective for ischemic stroke

Yu-Hui Zhao et al. CNS Neurosci Ther. 2013 Feb.

Abstract

Endothelial progenitor cells (EPCs), which can be cultured in vitro from mononuclear cells in peripheral blood or bone marrow, express both hematopoietic stem cell and endothelial cell markers on their surface. They are believed to participate in endothelial repair and postnatal angiogenesis due to their abilities of differentiating into endothelial cells and secreting protective cytokines and growth factors. Mounting evidence suggests that circulating EPCs are reduced and dysfunctional in various diseases including hypertension, diabetes, coronary heart disease, and ischemic stroke. Therefore, EPCs have been documented to be a potential biomarker for vascular diseases and a hopeful candidate for regenerative medicine. Ischemic stroke, as the major cause of disability and death, still has limited therapeutics based on the approaches of vascular recanalization or neuronal protection. Emerging evidence indicates that transplantation of EPCs is beneficial for the recovery of ischemic cerebral injury. EPC-based therapy could open a new avenue for ischemic cerebrovascular disease. Currently, clinical trials for evaluating EPC transfusion in treating ischemic stroke are underway. In this review, we summarize the general conceptions and the characteristics of EPCs, and highlight the recent research developments on EPCs. More importantly, the rationale, perspectives, and strategies for using them to treat ischemic stroke will be discussed.

© 2012 Blackwell Publishing Ltd.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1

Figure 1

EPC

function and therapeutic mechanism of

EPC

s for ischemic stroke.

Similar articles

Cited by

References

    1. Roger VL, Go AS, Lloyd‐Jones DM, et al. Executive summary: Heart disease and stroke statistics–2012 update: A report from the American Heart Association. Circulation 2012;125:188–197. - PubMed
    1. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation 2011;124:314–323. - PubMed
    1. Brott T, Broderick J, Kothari R, et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt‐PA Stroke Study Group. N Engl J Med 1995;333:1581–1587. - PubMed
    1. Lee M, Hong KS, Saver JL. Efficacy of intra‐arterial fibrinolysis for acute ischemic stroke: Meta‐analysis of randomized controlled trials. Stroke 2010;41:932–937. - PubMed
    1. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources